188 related articles for article (PubMed ID: 36814799)
21. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS.
Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G
Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China.
Huang R; Cheng Z; Jin X; Yu X; Yu J; Guo Y; Zong L; Sheng J; Liu X; Wang S
Ann Med; 2022 Dec; 54(1):622-632. PubMed ID: 35175162
[TBL] [Abstract][Full Text] [Related]
23. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
24. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
Xie X; Li Q; Zhang L; Ren W
Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
[TBL] [Abstract][Full Text] [Related]
25. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.
Başar Gökcen B; Akdevelioğlu Y; Canan S; Bozkurt N
Eat Weight Disord; 2021 Jun; 26(5):1581-1593. PubMed ID: 32772321
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome.
Kabakchieva P; Gateva A; Velikova T; Georgiev T; Yamanishi K; Okamura H; Kamenov Z
Arch Endocrinol Metab; 2022 Mar; 66(1):3-11. PubMed ID: 35263047
[TBL] [Abstract][Full Text] [Related]
28. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
[No Abstract] [Full Text] [Related]
29. Waist-to-height ratio and BMI as predictive markers for insulin resistance in women with PCOS in Kolkata, India.
Bhattacharya K; Sengupta P; Dutta S; Chaudhuri P; Das Mukhopadhyay L; Syamal AK
Endocrine; 2021 Apr; 72(1):86-95. PubMed ID: 33400176
[TBL] [Abstract][Full Text] [Related]
30. Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods.
Kałużna M; Czlapka-Matyasik M; Bykowska-Derda A; Moczko J; Ruchala M; Ziemnicka K
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444654
[TBL] [Abstract][Full Text] [Related]
31. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients.
Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A
Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690
[No Abstract] [Full Text] [Related]
32. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.
Cai J; Wu CH; Zhang Y; Wang YY; Xu WD; Lin TC; Li SX; Wang LH; Zheng J; Sun Y; Liu W; Tao T
Int J Obes (Lond); 2017 Sep; 41(9):1341-1347. PubMed ID: 28487551
[TBL] [Abstract][Full Text] [Related]
33. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
34. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
[TBL] [Abstract][Full Text] [Related]
35. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
36. Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome.
Kulik-Kupka K; Jabczyk M; Nowak J; Jagielski P; Hudzik B; Zubelewicz-Szkodzińska B
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235688
[TBL] [Abstract][Full Text] [Related]
37. Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.
Zhou C; Zhan L; Yuan J; Tong X; Peng Y; Zha Y
Eat Weight Disord; 2020 Jun; 25(3):727-734. PubMed ID: 30968371
[TBL] [Abstract][Full Text] [Related]
38. Assessment of insulin resistance and metabolic syndrome in young reproductive aged women with polycystic ovarian syndrome: analogy of surrogate indices.
Rashid N; Nigam A; Kauser S; Prakash P; Jain SK; Wajid S
Arch Physiol Biochem; 2022 Jun; 128(3):740-747. PubMed ID: 32037881
[TBL] [Abstract][Full Text] [Related]
39. Comparison of novel visceral obesity indexes with traditional obesity measurements in predicting of metabolically unhealthy nonobese phenotype in hemodialysis patients.
Zhou C; Peng Y; Jiang W; Yuan J; Zha Y
BMC Endocr Disord; 2021 Dec; 21(1):244. PubMed ID: 34923974
[TBL] [Abstract][Full Text] [Related]
40. Association between visceral adiposity index, hirsutism and cardiometabolic risk factors in women with polycystic ovarian syndrome: A cross-sectional study.
Fonseka S; Subhani B; Wijeyaratne CN; Gawarammana IB; Kalupahana NS; Ratnatunga N; Rosairo S; Vithane KP
Ceylon Med J; 2019 Sep; 64(3):111-117. PubMed ID: 32120461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
